AMRN
NASDAQ
$13.60
Amarin Corp (AMRN)
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Sell
Target: $12 (-11.76%)
Market Cap
$303M
PEG Ratio
0.81
P/B Ratio
0.68
Free Cash Flow Yield
8.43%
Price Chart
Valuation
Market Cap$303M
Forward P/E500.00
PEG0.81
P/S1.39
P/B0.68
Profitability
Total Revenue (TTM)$217M
Gross Profit (TTM)$114M
EBITDA-$31M
Profit Margin-23.3%
Operating Margin-25.1%
EPS-$1.61
Financial Health
Free Cash Flow Yield8.43%
Growth & Risk
Revenue 5Y CAGR-18.46%
Beta (5Y)0.78
Sharpe Ratio-0.20